Fund moves
5.0%Stake
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Stake as of Sep 30, 2026 · Filed Nov 16, 2026
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Undefined
Compared with the manager's prior 13F
—
NaN
For the same quarter
Fund moves
The holder reported owning less than 5%, which ends its duty to keep reporting this stake.
Insider buying
Traded Aug 14 · filed 4 days later
The CEO of Verrica Pharmaceuticals paid $101K out of pocket for Verrica Pharmaceuticals shares. 3 other people at Verrica Pharmaceuticals bought some too, in the same month. It was the first purchase in 9 months.
Insider buying
3 insiders in a week, 6th time since 2018Traded Aug 17 · filed 1 day later
Verrica Pharmaceuticals's CMO paid $21K out of pocket for Verrica Pharmaceuticals shares. 3 other people at Verrica Pharmaceuticals bought some too, in the same month. It was the first purchase in 9 months.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.